BioPharma Dive1h
AbbVie’s $9B bet collapses as closely watched schizophrenia drug fails studies
Shares in AbbVie slumped by double digits Monday after the company disclosed its psychiatric medicine emraclidine didn’t best ...
BioPharma Dive1h
FDA lifts pause on Novavax flu vaccine trials
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
BioPharma Dive1h
FDA approves new CAR-T competitor to Gilead’s Tecartus
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...
BioPharma Dive3h
Thinking inside the box: How SmartLabs is driving new collaborations to support the life science industry in global innovation hubs
“As the industry transitions from traditional drug discovery and life sciences R&D to faster-paced, complex modalities, ...